Metabolites of Neostigmine and Pyridostigmine Do Not Contribute to Antagonism of Neuromuscular Blockade in the Dog
作者:
Pim Hennis,
Roy Cronnelly,
Manohar Sharma,
Dennis Fisher,
Ronald Miller,
期刊:
Anesthesiology
(OVID Available online 1984)
卷期:
Volume 61,
issue 5
页码: 534-539
ISSN:0003-3022
年代: 1984
出版商: OVID
关键词: Antagonists,;neuromuscular relaxants:;edrophonium;;neostigmine;;pyridostigmine.;Metabolites:;neostigmine;;pyridostigmine.;Pharmacokinetics.
数据来源: OVID
摘要:
The authors sought to determine whether the metabolites of neostigmine and pyridostigmine contribute to antagonism of neuromuscular blockade. Accordingly, the dose-response relationship, onset and duration of action (n = 60), and pharmacokinetics (n = 22) of neostigmine, pyridostigmine, their metabolites 3-hydroxyphenyltrimethylammonium (PTMA) and 3-hydroxy-N-methylpyridinium (MP), and edrophonium were determined in dogs anesthetized with sodium pentobarbital. The force of contraction of the anterior tibialis muscle was maintained at constant 90% depression by infusing pancuronium. Then, a single iv bolus dose of one of the drugs under study was injected while the pancuronium infusion was continued. Venous blood, urine, and bile were sampled for four hours. Concentrations were determined by liquid chromatographic techniques; a three-compartment pharmacokinetic model was fitted to the serum concentration data. The doses producing 50% antagonism were 6.5, 52, 69, and 40 μg/kg for neostigmine, pyridostigmine, edrophonium, and PTMA, respectively. MP was inactive as an antagonist. By comparing approximately equipotent doses, time to peak antagonism (onset) and until 30% of peak antagonism remained (duration) were shorter for both edrophonium and PTMA than for neostigmine and pyridostigmine. Slow distribution and elimination half-lives, volume of distribution at steady state (VDss), and total plasma clearance (Cl) were similar for the drugs except for a smaller Vdssand lower Cl for MP. More than 60% of the dose of each drug was recovered unchanged from urine; less than 1% was recovered from bile. Less than 10% of the dose of neostigmine was recovered as PTMA. Since PTMA was a weak antagonist and MP had no antagonist activity, the authors conclude that their contribution to antagonism of neuromuscular blockade is minimal. Therefore, the slower onset of neostigmine and pyridostigmine than of edrophonium cannot result from the time required for the formation of their metabolites. Also, differences in potency and duration between the drugs cannot be explained by pharmacokinetics. These results support the belief that there are pharmacodynamic differences between the drugs.
点击下载:
PDF
(477KB)
返 回